UFPT vs. PLSE, IRMD, SPNE, UTMD, ARAY, GPK, SEE, SON, PKG, and SOLV
Should you be buying UFP Technologies stock or one of its competitors? The main competitors of UFP Technologies include Pulse Biosciences (PLSE), Iradimed (IRMD), SeaSpine (SPNE), Utah Medical Products (UTMD), Accuray (ARAY), Graphic Packaging (GPK), Sealed Air (SEE), Sonoco Products (SON), Packaging Co. of America (PKG), and Solventum (SOLV).
UFP Technologies (NASDAQ:UFPT) and Pulse Biosciences (NASDAQ:PLSE) are both industrial products companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, community ranking, profitability and analyst recommendations.
UFP Technologies has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.
Pulse Biosciences received 39 more outperform votes than UFP Technologies when rated by MarketBeat users. Likewise, 64.83% of users gave Pulse Biosciences an outperform vote while only 59.26% of users gave UFP Technologies an outperform vote.
UFP Technologies has a net margin of 11.75% compared to Pulse Biosciences' net margin of 0.00%. UFP Technologies' return on equity of 17.40% beat Pulse Biosciences' return on equity.
87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are held by institutional investors. 6.2% of UFP Technologies shares are held by company insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
UFP Technologies presently has a consensus target price of $323.50, indicating a potential upside of 0.37%. Given UFP Technologies' higher probable upside, analysts plainly believe UFP Technologies is more favorable than Pulse Biosciences.
In the previous week, UFP Technologies had 2 more articles in the media than Pulse Biosciences. MarketBeat recorded 6 mentions for UFP Technologies and 4 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.98 beat UFP Technologies' score of 0.96 indicating that Pulse Biosciences is being referred to more favorably in the news media.
UFP Technologies has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500.
Summary
UFP Technologies beats Pulse Biosciences on 11 of the 17 factors compared between the two stocks.
Get UFP Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for UFPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UFPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
UFP Technologies Competitors List
Related Companies and Tools
Free UFPT Stock Alerts